Cargando…
Covid-19-vaccine-pfizer-biontech: Urticarial vasculitis: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8532467/ http://dx.doi.org/10.1007/s40278-021-04139-5 |
Ejemplares similares
-
Covid-19-vaccine-pfizer-biontech: Leukocytoclastic vasculitis: case report
Publicado: (2022) -
Covid-19-vaccine-pfizer-biontech: Leukocytoclastic vasculitis: case report
Publicado: (2022) -
Covid-19-vaccine-pfizer-biontech: IgA-dominant leukocytoclastic vasculitis: case report
Publicado: (2021) -
ANCA-Associated Vasculitis Following Pfizer-BioNTech COVID-19 Vaccine
por: Shakoor, Muhammad Tariq, et al.
Publicado: (2021) -
COVID-19-Vaccine-Pfizer-BioNTech/pegfilgrastim/pembrolizumab: Large vessel vasculitis: case report
Publicado: (2022)